A A A

Follow our work


Click the button below to support our research 

JustGiving Donate

Phase I trial to determine the safety of transplanting stem cell-derived retinal cells

Phase I trial to determine the safety of transplanting stem cell-derived retinal cells for people with Stargardt Macular Degeneration

We are conducting Europe's first clinical trial looking at the safety of injecting retinal cells, derived from embryonic stem cells, into the eyes of patients with Stargardt macular dystrophy.

Stargardt Disease
White flecks as seen in Stargardt disease


The cells being injected are retinal pigment epithelium (RPE) cells that were grown from human embryonic stem cells in a dish, by the American company Advanced Cell Technology Inc.

This trial involves patients who are already severely visually impaired and is designed to show whether the injection of these cells is safe - future studies will be required to determine if cell transplantation can restore sight.

Page last modified on 07 jul 15 13:38